Long-term mortality and morbidity after carotid endarterectomy for symptomatic and asymptomatic carotid stenosis.

Carotid Carotid Stenosis Cause of Death Endarterectomy Ischemic Stroke Morbidity

Journal

Annals of vascular surgery
ISSN: 1615-5947
Titre abrégé: Ann Vasc Surg
Pays: Netherlands
ID NLM: 8703941

Informations de publication

Date de publication:
06 Aug 2024
Historique:
received: 10 04 2024
revised: 08 07 2024
accepted: 17 07 2024
medline: 9 8 2024
pubmed: 9 8 2024
entrez: 8 8 2024
Statut: aheadofprint

Résumé

To investigate whether the occurrence of ischemic stroke due to carotid stenosis is a marker of the severity of atherosclerotic disease and of an excess risk of cardiovascular morbidity and mortality, and of all-cause mortality, after carotid endarterectomy. Patients who had undergone a carotid endarterectomy (CEA) from June 2015 to august 2016 were included. Patients were classified into two groups, namely symptomatic and asymptomatic. Neurological event, myocardial infarction and death during early follow-up were monitored. Major adverse cardiovascular events (MACE), major limb events (MALE), and all-cause mortality were compared for patients with a CEA for an asymptomatic carotid stenosis versus those with a symptomatic stenosis. Among the 190 patients included, 86 (51%) had a CEA for an asymptomatic stenosis and 84 (49%) for a symptomatic stenosis. During the first 30 days, the rate of all-cause death or ischemic stroke was similar in both groups (1%, p=0.986). After 30 days, there were a total of 35 MACE (21.3%) and 15 MALE (9.1%) during mean follow-up of 53 (22.6) months. Overall cardiovascular morbidity and mortality was 30.4%, and did not differ between groups (p=0.565). New ischemic stroke occurred in 11 patients (9.1%) and was significantly more frequent in the asymptomatic group (9 (14.8%) vs 2 (3.6%) in the symptomatic group, (OR: 4.96; CI 95% [1.04-23.77]; p = 0.013)). Overall all-cause mortality was 24% in both groups (p=0.93) CONCLUSION: The occurrence of ischemic stroke of carotid origin prior to revascularization does not appear to be associated with an excess risk of cardiovascular morbidity or mortality or all-cause mortality after surgery.

Identifiants

pubmed: 39116939
pii: S0890-5096(24)00463-1
doi: 10.1016/j.avsg.2024.07.085
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Auteurs

Philippe Tresson (P)

Hospices Civils de Lyon, Hôpital Louis Pradel, Service de Chirurgie Vasculaire et Endovasculaire, Bron cedex, F-69500. Electronic address: philippe.tresson@chu-lyon.fr.

Stéphane Lo (S)

Hospices Civils de Lyon, Hôpital Edouard Herriot, Service de Médecine Interne et de Médecine Vasculaire, Lyon cedex, F-69003; Université de Lyon, University Claude Bernard Lyon 1, Lyon, France.

Emeraude Rivoire (E)

Hospices Civils de Lyon, Hôpital Edouard Herriot, Service de Médecine Interne et de Médecine Vasculaire, Lyon cedex, F-69003; Université de Lyon, University Claude Bernard Lyon 1, Lyon, France.

Tae-Hee Cho (TH)

Department of Vascular Neurology, Hospices Civils de Lyon, Université Lyon 1, France. CarMeN, INSERM-U1060, INRA-U1397, INSA-Lyon, Université Lyon 1, France.

Antoine Millon (A)

Hospices Civils de Lyon, Hôpital Louis Pradel, Service de Chirurgie Vasculaire et Endovasculaire, Bron cedex, F-69500; Université de Lyon, University Claude Bernard Lyon 1, Lyon, France.

Anne Long (A)

Hospices Civils de Lyon, Hôpital Edouard Herriot, Service de Médecine Interne et de Médecine Vasculaire, Lyon cedex, F-69003; Université de Lyon, University Claude Bernard Lyon 1, Lyon, France.

Classifications MeSH